Publication:
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.

Loading...
Thumbnail Image

Date

2022-10-05

Authors

Wu, Wendy Yi-Ying
Haider, Zahra
Feng, Xiaoshuang
Heath, Alicia K
Tjønneland, Anne
Agudo, Antonio
Masala, Giovanna
Robbins, Hilary A
Huerta, Jose-Maria
Guevara, Marcela

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

John Wiley & Sons, Inc.
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The EarlyCDT-Lung test is a blood-based autoantibody assay intended to identify high-risk individuals for low-dose computed tomography lung cancer screening. However, there is a paucity of evidence on the performance of the EarlyCDT-Lung test in ever-smokers. We conducted a nested case-control study within two prospective cohorts to evaluate the risk-discriminatory performance of the EarlyCDT-Lung test using prediagnostic blood samples from 154 future lung cancer cases and 154 matched controls. Cases were selected from those who had ever smoked and had a prediagnostic blood sample

Description

MeSH Terms

Humans
Lung Neoplasms
Case-Control Studies
Retrospective Studies
Early Detection of Cancer
Smokers
Prospective Studies
Biomarkers
Lung

DeCS Terms

Biomarcadores
Detección precoz del cáncer
Estudios prospectivos
Estudios retrospectivos
Estudios de casos y controles
Fumadores
Humanos
Neoplasias pulmonares
Pulmón

CIE Terms

Keywords

EarlyCDT-Lung test, biomarkers, lung cancer, prediagnostic samples

Citation

Wu WY, Haider Z, Feng X, Heath AK, Tjønneland A, Agudo A, et al. Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts. Int J Cancer. 2023 May 1;152(9):2002-2010.